These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 27539899)
1. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale. Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899 [TBL] [Abstract][Full Text] [Related]
2. Characteristics of Xeroderma Pigmentosum in Japan: Lessons From Two Clinical Surveys and Measures for Patient Care. Nishigori C; Nakano E; Masaki T; Ono R; Takeuchi S; Tsujimoto M; Ueda T Photochem Photobiol; 2019 Jan; 95(1):140-153. PubMed ID: 30565713 [TBL] [Abstract][Full Text] [Related]
3. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal. Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624 [TBL] [Abstract][Full Text] [Related]
4. Melanoma and other skin cancers in xeroderma pigmentosum patients and mutation in their cells. Takebe H; Nishigori C; Tatsumi K J Invest Dermatol; 1989 May; 92(5 Suppl):236S-238S. PubMed ID: 2715657 [TBL] [Abstract][Full Text] [Related]
5. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Kraemer KH; Lee MM; Andrews AD; Lambert WC Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698 [TBL] [Abstract][Full Text] [Related]
6. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients. Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234 [TBL] [Abstract][Full Text] [Related]
7. Xeroderma pigmentosum clinical practice guidelines. Moriwaki S; Kanda F; Hayashi M; Yamashita D; Sakai Y; Nishigori C; J Dermatol; 2017 Oct; 44(10):1087-1096. PubMed ID: 28771907 [TBL] [Abstract][Full Text] [Related]
8. Mutational spectrum of Xeroderma pigmentosum group A in Egyptian patients. Amr K; Messaoud O; El Darouti M; Abdelhak S; El-Kamah G Gene; 2014 Jan; 533(1):52-6. PubMed ID: 24135642 [TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of brain atrophy in patients with xeroderma pigmentosum group A carrying the founder mutation in Japan. Ueda T; Kanda F; Nishiyama M; Nishigori C; Toda T J Neurol Sci; 2017 Oct; 381():103-106. PubMed ID: 28991657 [TBL] [Abstract][Full Text] [Related]
10. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions. Sethi M; Lehmann AR; Fawcett H; Stefanini M; Jaspers N; Mullard K; Turner S; Robson A; McGibbon D; Sarkany R; Fassihi H Br J Dermatol; 2013 Dec; 169(6):1279-87. PubMed ID: 23889214 [TBL] [Abstract][Full Text] [Related]
11. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum. Spatz A; Giglia-Mari G; Benhamou S; Sarasin A Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118 [TBL] [Abstract][Full Text] [Related]
12. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma. Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756 [TBL] [Abstract][Full Text] [Related]
13. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum. Lambert WC; Lambert MW Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223 [TBL] [Abstract][Full Text] [Related]
14. Identification of a primarily neurological phenotypic expression of xeroderma pigmentosum complementation group A in a Tunisian family. Messaoud O; Ben Rekaya M; Kefi R; Chebel S; Boughammoura-Bouatay A; Bel Hadj Ali H; Gouider-Khouja N; Zili J; Frih-Ayed M; Mokhtar I; Abdelhak S; Zghal M Br J Dermatol; 2010 Apr; 162(4):883-6. PubMed ID: 20199544 [TBL] [Abstract][Full Text] [Related]
15. A prevalent mutation with founder effect in xeroderma pigmentosum group C from north Africa. Soufir N; Ged C; Bourillon A; Austerlitz F; Chemin C; Stary A; Armier J; Pham D; Khadir K; Roume J; Hadj-Rabia S; Bouadjar B; Taieb A; de Verneuil H; Benchiki H; Grandchamp B; Sarasin A J Invest Dermatol; 2010 Jun; 130(6):1537-42. PubMed ID: 20054342 [TBL] [Abstract][Full Text] [Related]
18. Incidence of xeroderma pigmentosum in Larkana, Pakistan: a 7-year study. Bhutto AM; Shaikh A; Nonaka S Br J Dermatol; 2005 Mar; 152(3):545-51. PubMed ID: 15787826 [TBL] [Abstract][Full Text] [Related]
19. A 10-year follow-up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole-genome sequencing. Ono R; Masaki T; Mayca Pozo F; Nakazawa Y; Swagemakers SM; Nakano E; Sakai W; Takeuchi S; Kanda F; Ogi T; van der Spek PJ; Sugasawa K; Nishigori C Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):174-80. PubMed ID: 26993158 [TBL] [Abstract][Full Text] [Related]